Loading
A phase 2 trial of Epetraborole run by AN2 Therapeutics, Inc, not yet recruiting.
Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera is a phase 2 interventional study registered as NCT07891533 by AN2 Therapeutics, Inc, with 75 participants planned, started 2026-11, primary completion expected 2029-04. Conditions recorded: Polycythemia Vera (SNOMED CT: 109992005). Interventions recorded: Epetraborole, Placebo.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Shares Polycythaemia vera (PV) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/